Yes, Kevzara Comes in Pre-Filled Syringes
Kevzara (sarilumab), used for rheumatoid arthritis and other inflammatory conditions, is available in pre-filled syringes for subcutaneous injection. These are single-dose, auto-injector-style syringes containing 200 mg/1.4 mL or 150 mg/1.4 mL solutions, making home administration straightforward.[1]
How Do You Use the Pre-Filled Syringe?
Patients inject subcutaneously in the thigh, abdomen, or upper arm every two weeks. The syringe has a needle cover that retracts after injection for safety. Full instructions and a step-by-step guide are in the FDA-approved prescribing information; training from a healthcare provider is recommended for first use.[1][2]
What About Other Forms or Dosages?
Kevzara is also available as a pre-filled pen (autoinjector) in the same strengths, offering an alternative for those preferring less manual handling. No vial or IV forms exist for patient use—only subcutaneous options.[1]
Who Makes Kevzara and Where to Get It?
Sanofi and Regeneron co-developed and market Kevzara. It's prescription-only, covered by most insurance plans with prior authorization. Patient assistance programs like the Kevzara Co-Pay Program help with costs.[2][3]
Any Patent or Availability Issues?
Kevzara's main patents expire around 2032, with no biosimilars approved yet. Supply is generally stable, but check with pharmacies for local stock.[4]
[1]: FDA Kevzara Prescribing Information
[2]: Kevzara Official Website
[3]: Sanofi Patient Assistance
[4]: DrugPatentWatch.com - Kevzara Patents